期刊： CURRENT DRUG TARGETS, 2023; 24 (16)
The review is devoted to the development and study of the drug Leukovir (R) (cladribine+ribavirin) and its use in the treatment of relapsing-remitting......
期刊： CURRENT DRUG TARGETS, 2023; 24 (12)
Introduction Glioblastoma Multiforme (GBM) has a poor prognosis, with current treatments providing no advantage in terms of survival. Certain new immu......
期刊： CURRENT DRUG TARGETS, 2023; 24 (12)
Stimulator of interferon genes (STING) plays a vital role in the human innate immune system. Aberrant expression of STING has been proven to be associ......
期刊： CURRENT DRUG TARGETS, 2023; 24 (1)
Brain tumors have become one of the deadliest cancers; however, their treatment is still limited by conventional approaches. Brain tumors, among other......
期刊： CURRENT DRUG TARGETS, 2023; 24 (16)
Introduction: Rosa webbiana (RW) Wall Ex. Royle is used in traditional medicine in Pakistan for the treatment of several diseases including jaundice. ......
期刊： CURRENT DRUG TARGETS, 2023; 24 (7)
Proteostasis is crucial for the maintenance and proper operation of cells. Under typical circumstances, the ubiquitin-proteasome system (UPS) and the ......
期刊： CURRENT DRUG TARGETS, 2023; 24 (15)
Pyroptosis has become a noteworthy area of focus in recent years due to its association with inflammatory diseases. Pyroptosis is a type of programmed......
期刊： CURRENT DRUG TARGETS, 2023; 24 (10)
Cancer is a complex disease that develops when abnormal cells divide uncontrollably as a consequence of unregulated cell cycle protein activity. There......
期刊： CURRENT DRUG TARGETS, 2023; 24 (5)
Background Parasitic human infectious diseases are a worldwide health problem due to the increased resistance to conventional drugs. For this reason, ......
期刊： CURRENT DRUG TARGETS, 2023; ()
Glaucoma is the most common cause of irreversible blindness worldwide. It is characterized by progressive optic nerve degeneration and loss of visual ......
期刊： CURRENT DRUG TARGETS, 2023; 24 (3)
Background: Epilepsy is a neurological disease affected by an imbalance of inhibitory and excitatory signaling in the brain. Introduction: In this dis......
期刊： CURRENT DRUG TARGETS, 2023; 24 (6)
MicroRNAs have a plethora of roles in various biological processes in the cells and most human cancers have been shown to be associated with dysregula......
